AUG 30, 2016 08:00 AM PDT

Directed differentiation of induced pluripotent stem cells to hepatic stellate cells

Speakers
  • IDIBAPS Researcher, Institut d'Investigacions Biomediques August Pi i Sunyer (IDIBAPS), Spain
    Biography
      Pau Sancho-Bru received his PhD in 2006 from the University of Barcelona. In 2007 he joined the Stem Cell Institute Leuven at the KU Leuven, Belgium as a postdoctoral researcher. In 2012 he was appointed Researcher in IDIBAPS. Pau Sancho-Bru is Principal Investigator at the Liver Injury and Repair Group and Researcher at IDIBAPS. His group is focused on understanding the mechanisms governing liver injury and regeneration and particularly the role of hepatic stellate cells and liver stem/progenitor cells in wound-healing responses. One of the main research interests of his group is developing in vitro systems for disease modeling and assessing the potential of stem cells for biomedical and biotechnological applications.

    Abstract:
    In healthy liver, quiescent hepatic stellate cells (HSCs) participate in the homeostasis of extracellular matrix and store vitamin A. After injury, HSCs activate and participate in the wound-healing response, producing extracellular matrix components and eventually fibrosis.  We have developed a protocol to direct the differentiation of human induced pluripotent stem cells (iPSC) to HSCs. The final HSC–like population was enriched in PDGFRß positive cells and expressed key HSC markers at similar levels than primary HSC. Whole genome transcriptomic analysis revealed that PSC-derived population displayed an intermediate phenotype between activated and quiescent HSCs. Functional analysis showed that PSC-derived HSC-like cells responded to injury mediators and accumulated retinyl esters into lipid droplets. These findings show that we have generated functional HSC-like cells from iPSC, which may have potential for in vitro and biomedical applications

    Show Resources
    You May Also Like
    JUN 18, 2019 04:00 PM CEST
    C.E. CREDITS
    JUN 18, 2019 04:00 PM CEST
    DATE: June 18, 2019TIME: 7:00am PDT, 10:00 EDT, 4:00pm CET PSCs represent an important tool in a wide range of applications, including basic research, disease modeling, drug...
    JUN 19, 2019 10:00 AM PDT
    JUN 19, 2019 10:00 AM PDT
    DATE: June 19, 2019TIME: 10:00am PDT, 1:00pm EDT As we develop new methods to create more biologically relevant models for research in understanding disease etiology and in...
    JUN 05, 2019 05:00 PM CEST
    C.E. CREDITS
    JUN 05, 2019 05:00 PM CEST
    DATE: June 5, 2019TIME: 8:00am PDT, 11:00am EDT, 5:00pm CEST Eukaryotic cell cultures respond to the most subtle influence. Apart from the risk of contamination, minimal chan...
    SEP 05, 2019 04:00 PM CEST
    C.E. CREDITS
    SEP 05, 2019 04:00 PM CEST
    DATE: September 5, 2019TIME: 7:00am PT, 10:00am ET, 4:00pm CEST PCR (Polymerase Chain Reaction) has gone through a massive evolution since its development in 1983. Besides it...
    MAR 20, 2019 09:00 AM PDT
    C.E. CREDITS
    MAR 20, 2019 09:00 AM PDT
    DATE:  March 20, 2019TIME:  9:00am PDT...
    AUG 27, 2019 09:00 AM PDT
    C.E. CREDITS
    AUG 27, 2019 09:00 AM PDT
    DATE: August 27, 2019 TIME: 9:00am PDT, 12:00pm EDT Immunotherapies targeting PD-1 or PD-L1 have proven remarkably effective for treating cancer in some patients, with considerabl...
    Loading Comments...
    Show Resources
    Attendees